![Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database](https://www.mdpi.com/brainsci/brainsci-10-00105/article_deploy/html/images/brainsci-10-00105-g001.png)
Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Ba
![The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom Profiles | Neuropsychopharmacology The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom Profiles | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1016%2FS0893-133X%2899%2900103-7/MediaObjects/41386_1999_Article_BF1395427_Fig1_HTML.jpg)
The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom Profiles | Neuropsychopharmacology
![PDF) A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder PDF) A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder](https://i1.rgstatic.net/publication/331217409_A_case_report_of_cholinergic_rebound_syndrome_following_abrupt_low-dose_clozapine_discontinuation_in_a_patient_with_type_I_bipolar_affective_disorder/links/5fc22304458515b7977ccb61/largepreview.png)
PDF) A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder
![High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure - Innovations in Clinical Neuroscience High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure - Innovations in Clinical Neuroscience](https://innovationscns.com/wp-content/uploads/ICNS-July-August-2019-Demler-Main-Art.jpg)
High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure - Innovations in Clinical Neuroscience
![Management of Cholinergic Rebound After Abrupt Withdrawal of Clozapine: A Case Report and Systematic Literature Review - ScienceDirect Management of Cholinergic Rebound After Abrupt Withdrawal of Clozapine: A Case Report and Systematic Literature Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2667296023001313-gr1.jpg)
Management of Cholinergic Rebound After Abrupt Withdrawal of Clozapine: A Case Report and Systematic Literature Review - ScienceDirect
![PDF] Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database | Semantic Scholar PDF] Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2bcd9e2a77af617a2aa20be903e3fc88e0ab3b06/11-Table5-1.png)
PDF] Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database | Semantic Scholar
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Symptoms-of-Antipsychotic-Withdrawal-Syndrome.png)
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
![Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database](https://pub.mdpi-res.com/brainsci/brainsci-10-00105/article_deploy/html/images/brainsci-10-00105-g002.png?1583586013)
Brain Sciences | Free Full-Text | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Clozapine-Doses-and-D2-receptor-occupancies-.png)